ADAR1 Capital Management, LLC - Jun 28, 2024 Form 3 Insider Report for Acasti Pharma Inc. (ACST)

Role: 10%+ Owner
Signature: ADAR1 Capital Management, LLC, By /s/ Daniel Schneeberger, Manager
Stock symbol: ACST
Transactions as of: Jun 28, 2024
Transactions value $: $0
Form type: 3
Date filed: 7/9/2024, 08:29 PM
Next filing: Jul 31, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ACST	Class A Common Stock						960K	Jun 28, 2024	By: ADAR1 Partners	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	ADAR1 Capital Management GP, LLC is the general partner of ADAR1 Partners, LP ("ADAR1 Partners").
F2	ADAR1 Capital Management, LLC ("ADAR1 Capital"), an entity owned and controlled by Dr. Daniel Schneeberger, owns voting and investment control with respect to the shares held by ADAR1 Partners, LP. Because of the relationship between ADAR1 Partners and ADAR1 Capital, ADAR1 Capital may be deemed to beneficially own the shares held directly by ADAR1 Partners.
F3	For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.